Organisation paid for research Program year 2025 Source: CMS Open Payments

Trustees of Columbia Univ in the City of NY, the

Neither a doctor nor a teaching hospital

Research payments

$817,391

21 payments

Through program year 2025, Trustees of Columbia Univ in the City of NY, the is reported as receiving $817,391 in research payments, across 21 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$70,461	5
2023	Research	$453,305	8
2020	Research	$133,841	3
2019	Research	$159,784	5

Breakdown

Who paid Research payments · program years 2019–2025

Amgen Inc. $817,391 21 payments

Studies the money was for Research payments · program years 2019–2025

AMG 510 Ph1b Master Protocol 20190135 $349,979 3 payments
AMG 701_Non-Randomized Open-Label Expansion_Multiple Myeloma_20170122 $120,505 2 payments
AMG 701 Ph1/2 Non-Randomized Open-Label Expansion MM $92,238 1 payment
P0 ASCVD Olpasiran Prescreening for CVOT $61,680 1 payment
P1b talimogene laherparepvec + PD-L1 Combo (Agent and Tumor Type (CRC +TNBC) $43,134 2 payments
A Phase 1/2 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 701 Monotherapy, or in Combination With Pomalidomide, With and Without Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (ParadigMM-1B) $38,582 1 payment
AMG 510 - Adv. KRAS G12C solid tumors_20190135 $20,185 1 payment
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a) $18,924 1 payment
Phase P3 Pediatric Study (EM) $17,951 2 payments
P1b Monotherapy in Pediatric Patients $13,771 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.